Cardiopulmonary Changes Following Spinal Cord Stimulation in Individuals With Spinal Cord Injury
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19-65
SponsorUniversity of British Columbia
About this trial
The aim of this study is to examine the mechanisms of transcutaneous spinal cord stimulation (tSCS) for improving cardiovascular and pulmonary function in individuals with chronic motor-complete spinal cord injury (SCI) by measuring vascular related endothelial biomarkers, plasma catecholamines, and respiratory parameters.
Eligibility criteria
Qualifiers
None
Disqualifiers
Resident of British Columbia, Canada with active provincial medical services plan
Male or female, 19-65 years of age
Chronic SCI at or above the T10 spinal cord segment
>1-year post injury or diagnosis, at least 6 months from any spinal surgery.
Trial design
Treatments tested in this trial
- Transcutaneous Spinal Cord Stimulation (tSCS)
Treatment groups
22 Participants
are divided into 1 treatment groupLocations
1Blusson Spinal Cord CentreV5Z 1M9, VancouverBritish Columbia, Canada
Sponsors and collaborators
University of British Columbia
Lead sponsor
Source ClinicalTrials.gov